UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
PhyMatrix Corp.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
718925100
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5
<PAGE>
SCHEDULE 13G
CUSIP No. 718925100 Page 2 of 5
--- ---
1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Abraham D. Gosman
(###-##-####)
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
[ ]
(b)
[x]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF 5 SOLE VOTING POWER
8,487,126
SHARES
BENEFICIALLY 6 SHARED VOTING POWER
0
OWNED BY EACH
7 SOLE DISPOSITIVE POWER
REPORTING 8,487,126
PERSON WITH 8 SHARED DISPOSITIVE POWER
0
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,487,126
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
38.1%
12 TYPE OF REPORTING PERSON*
Individual (IN)
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 5
<PAGE>
Item 1(a) Name of Issuer
PhyMatrix Corp.
Item 1(b) Address of Issuer's Principal Executive Offices:
777 South Flagler Drive, West Palm Beach,
Florida 33401
Item 2(a) Name of Person Filing:
Abraham D. Gosman (###-##-####)
Item 2(b) Address of Principal Business Office:
The address of the reporting person is c/o PhyMatrix
Corp., 777 South Flagler Drive, West Palm Beach,
Florida 33401
Item 2(c) Citizenship:
The reporting person is a citizen of the United
States.
Item 2(d) Title of Class of Securities: Common Stock
Item 2(e) CUSIP Number: 718925 10 0
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned: Abraham D. Gosman
beneficially owns 8,487,126 shares of Common Stock of
the Issuer (4,000,000 of such shares of Common Stock
are held by Mr. Gosman as trustee for the benefit of
his sons, Michael Gosman and Andrew Gosman; as
trustee, Mr. Gosman has sole voting and dispositive
power with respect to the 4,000,000 shares held in
trust).
(b) Percent of Class: Mr. Gosman beneficially
owns 38.1% of the outstanding shares of Common
Stock.
(c) Mr. Gosman has the sole power to vote or to
direct the vote and the sole power to dispose or to
direct the disposition of 8,487,126 shares of Common
Stock.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person.
Michael Gosman and Andrew Gosman, the sons of
Abraham D. Gosman, may receive dividends paid with
respect to and proceeds from the sale of 2,000,000
shares of Common Stock held in trust for each of
them (i.e., 4,000,000 shares in the aggregate)
by Abraham D. Gosman.
Page 3 of 5
<PAGE>
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on by the Parent Holding
Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Page 4 of 5
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ Abraham D. Gosman
---------------------
Abraham D. Gosman
Date: February 12, 1997
Page 5 of 5
<PAGE>
Exhibit 1
Abraham D. Gosman
Andrew D. Gosman
Michael M. Gosman
